Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CRAFT DoSiDos is a medical cannabis flower product distributed by DEMECAN in Germany. It is derived from the 'Do-Si-Dos' cultivar, an indica-dominant hybrid strain created by crossing Girl Scout Cookies (GSC) and Face Off OG. The product is imported from Canada, where it is cultivated by Mill Creek Growth, and is distributed under the CRAFT brand (such as CRAFT DoSiDos 24:01, which contains approximately 24% to 25.8% THC and less than 1% CBD). CRAFT DoSiDos is prescribed for the treatment of various conditions, including chronic pain, spasticity, sleep disorders, and anxiety, acting primarily as a partial agonist at cannabinoid receptors CB1 and CB2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CRAFT DoSiDos.